TrialLancet (London, England)2019

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.

Walter R J Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.